Johnston Douglas 4
4 · LIPELLA PHARMACEUTICALS INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Johnston Douglas
Chief Financial Officer
Transactions
- Award
Stock Options
2024-03-15+50,000→ 50,000 totalExercise: $0.77From: 2024-03-15Exp: 2034-03-15→ Common Stock (50,000 underlying)